References
- 1Teng THK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, et al. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Lancet Global Heal. 2018; 6(9): e1008–e1018. DOI: 10.1016/S2214-109X(18)30306-1
- 2McMurray JJ, Packer M. How should we sequence the treatments for heart failure and a reduced ejection fraction? A redefinition of evidence-based medicine. Circulation. 2021; 143(9): 875–877. DOI: 10.1161/CIRCULATIONAHA.120.052926
- 3Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18): e895–e1032. DOI: 10.1161/CIR.0000000000001063
- 4Greene SJ, Butler J, Fonarow GC. Simultaneous or rapid sequence initiation of quadruple medical therapy for heart failure—optimizing therapy with the need for speed. JAMA Cardiol. 2021; 6(7). DOI: 10.1001/jamacardio.2021.0496
- 5Agarwal A, Yancy CW, Huffman MD. Improving care for heart failure with reduced ejection fraction—A potential polypill-based strategy. JAMA. 2020; 324(22): 2259–2260. DOI: 10.1001/jama.2020.21395
- 6Lam CSP, Anand I, Zhang S, Shimizu W, Narasimhan C, Park SW, et al. Asian sudden cardiac death in heart failure (ASIAN-HF) registry. Eur J Heart Fail. 2013; 15(8): 928–936. DOI: 10.1093/eurjhf/hft045
- 7Lam CSP, Teng THK, Tay WT, Anand I, Zhang S, Shimizu W, et al. Regional and ethnic differences among patients with heart failure in Asia: The Asian sudden cardiac death in heart failure registry. Eur Heart J. 2016; 37(41): 3141–3153. DOI: 10.1093/eurheartj/ehw331
- 8Rosano GMC, Moura B, Metra M, Böhm M, Bauersachs J, Ben Gal T, et al. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2021; 23(6): 872–881. DOI: 10.1002/ejhf.2206
- 9Vijay A, Mohanan PP, Kondal D, Baldridge A, Davies D, Devarajan R, et al. Polypill eligibility for patients with heart failure with reduced ejection fraction in South India: A secondary analysis of a prospective, interrupted time series study. J Am Heart Assoc. 2021; 10(20):
e021676 . DOI: 10.1161/JAHA.121.021676 - 10Santema BT, Ouwerkerk W, Tromp J, Sama IE, Ravera A, Regitz-Zagrosek V, et al. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Lancet. 2019; 394(10205): 1254–1263. DOI: 10.1016/S0140-6736(19)31792-1
- 11Bahiru E, Cates AN de, Farr MR, Jarvis MC, Palla M, Rees K, et al. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Db Syst Rev. 2017; 3. DOI: 10.1002/14651858.CD009868.pub3